Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Varex Imaging
VREX
Varex Imaging
Medical Imaging Risks Will Test Margins Yet Preserve Value
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
22 Jun 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$10.00
6.9% overvalued
intrinsic discount
09 Aug
US$10.69
Loading
1Y
-7.8%
7D
51.8%
Author's Valuation
US$10.0
6.9% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$10.0
6.9% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-132m
907m
2014
2017
2020
2023
2025
2026
2028
Revenue US$907.2m
Earnings US$176.2m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
3.89%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.52%
Calculation
US$176.17m
Earnings '28
x
3.26x
PE Ratio '28
=
US$575.17m
Market Cap '28
US$575.17m
Market Cap '28
/
43.44m
No. shares '28
=
US$13.24
Share Price '28
US$13.24
Share Price '28
Discounted to 2025 @ 10.18% p.a.
=
US$9.90
Fair Value '25
